Editpep is a biotechnology company developing a non-viral CRISPR delivery platform for in vivo genome editing, with an initial focus on therapies for neurological and other CNS diseases
Editpep is a biotechnology company developing a non-viral CRISPR delivery platform for in vivo genome editing, with an initial focus on therapies for neurological and other CNS diseases. Its PERC platform delivers CRISPR components to the brain and is being advanced toward preclinical development; the technology also has potential applications in ex vivo cell therapy.